CS
CALA

Credit Suisse’s Calithera Biosciences, Inc CALA Stock Holding History

Credit Suisse’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,536
Closed -$74K – 4717
2021
Q1 		$74K Sell
1,536
-1,049
-41% -$61.1K ﹤0.01% 4208
2020
Q4 		$254K Buy
2,585
+1,325
+105% +$116K ﹤0.01% 4033
2020
Q3 		$87K Buy
1,260
+431
+52% +$37.6K ﹤0.01% 3929
2020
Q2 		$88K Buy
+829
New +$98.5K ﹤0.01% 3844
2019
Q4 		– Sell
-584
Closed -$36K – 4398
2019
Q3 		$36K Sell
584
-326
-36% -$26.1K ﹤0.01% 4066
2019
Q2 		$71K Buy
+910
New +$103K ﹤0.01% 3976
2018
Q2 		– Sell
-1,706
Closed -$216K – 4206
2018
Q1 		$216K Buy
1,706
+73
+4% +$11.4K ﹤0.01% 3685
2017
Q4 		$273K Buy
1,633
+64
+4% +$16.4K ﹤0.01% 3660
2017
Q3 		$494K Sell
1,569
-42
-3% -$13.2K ﹤0.01% 3524
2017
Q2 		$479K Buy
+1,611
New +$431K ﹤0.01% 3175
2016
Q3 		– Sell
-2,659
Closed -$198K – 4316
2016
Q2 		$198K Buy
+2,659
New +$266K ﹤0.01% 3874
2015
Q3 		– Sell
-658
Closed -$94K – 4561
2015
Q2 		$94K Buy
+658
New +$153K ﹤0.01% 4402

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse's CALA Position: Q2 2021 in Review

Credit Suisse sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 1,536 shares — an estimated $74K sold.

Credit Suisse first reported a position in CALA in Q2 2015 and held it in 12 quarters. The position peaked at $494K in Q3 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Credit Suisse reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Credit Suisse sold 1,536 Calithera Biosciences, Inc shares in Q2 2021, an estimated $74K.
  • Credit Suisse first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 12 quarters.
  • Credit Suisse's Calithera Biosciences, Inc position peaked at $494K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.